Treating High-Risk Bladder Cancer and Analyzing PSA Screening for Prostate Cancer: Research From the 2021 Genitourinary Cancers Symposium
Learn more about research presented at the 2021 Genitourinary Cancers Symposium, including immunotherapy for people with high-risk bladder cancer and a link between less PSA screening and diagnoses of metastatic prostate cancer.